Cargando…
A user-friendly, open-source tool to project impact and cost of diagnostic tests for tuberculosis
Most models of infectious diseases, including tuberculosis (TB), do not provide results customized to local conditions. We created a dynamic transmission model to project TB incidence, TB mortality, multidrug-resistant (MDR) TB prevalence, and incremental costs over 5 years after scale-up of nine al...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
eLife Sciences Publications, Ltd
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4082287/ https://www.ncbi.nlm.nih.gov/pubmed/24898755 http://dx.doi.org/10.7554/eLife.02565 |
_version_ | 1782324238882963456 |
---|---|
author | Dowdy, David W Andrews, Jason R Dodd, Peter J Gilman, Robert H |
author_facet | Dowdy, David W Andrews, Jason R Dodd, Peter J Gilman, Robert H |
author_sort | Dowdy, David W |
collection | PubMed |
description | Most models of infectious diseases, including tuberculosis (TB), do not provide results customized to local conditions. We created a dynamic transmission model to project TB incidence, TB mortality, multidrug-resistant (MDR) TB prevalence, and incremental costs over 5 years after scale-up of nine alternative diagnostic strategies. A corresponding web-based interface allows users to specify local costs and epidemiology. In settings with little capacity for up-front investment, same-day microscopy had the greatest impact on TB incidence and became cost-saving within 5 years if delivered at $10/test. With greater initial investment, population-level scale-up of Xpert MTB/RIF or microcolony-based culture often averted 10 times more TB cases than narrowly-targeted strategies, at minimal incremental long-term cost. Xpert for smear-positive TB had reasonable impact on MDR-TB incidence, but at substantial price and little impact on overall TB incidence and mortality. This user-friendly modeling framework improves decision-makers' ability to evaluate the local impact of TB diagnostic strategies. DOI: http://dx.doi.org/10.7554/eLife.02565.001 |
format | Online Article Text |
id | pubmed-4082287 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | eLife Sciences Publications, Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-40822872014-07-22 A user-friendly, open-source tool to project impact and cost of diagnostic tests for tuberculosis Dowdy, David W Andrews, Jason R Dodd, Peter J Gilman, Robert H eLife Epidemiology and Global Health Most models of infectious diseases, including tuberculosis (TB), do not provide results customized to local conditions. We created a dynamic transmission model to project TB incidence, TB mortality, multidrug-resistant (MDR) TB prevalence, and incremental costs over 5 years after scale-up of nine alternative diagnostic strategies. A corresponding web-based interface allows users to specify local costs and epidemiology. In settings with little capacity for up-front investment, same-day microscopy had the greatest impact on TB incidence and became cost-saving within 5 years if delivered at $10/test. With greater initial investment, population-level scale-up of Xpert MTB/RIF or microcolony-based culture often averted 10 times more TB cases than narrowly-targeted strategies, at minimal incremental long-term cost. Xpert for smear-positive TB had reasonable impact on MDR-TB incidence, but at substantial price and little impact on overall TB incidence and mortality. This user-friendly modeling framework improves decision-makers' ability to evaluate the local impact of TB diagnostic strategies. DOI: http://dx.doi.org/10.7554/eLife.02565.001 eLife Sciences Publications, Ltd 2014-06-04 /pmc/articles/PMC4082287/ /pubmed/24898755 http://dx.doi.org/10.7554/eLife.02565 Text en Copyright © 2014, Dowdy et al http://creativecommons.org/licenses/by/3.0/ This article is distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0/) , which permits unrestricted use and redistribution provided that the original author and source are credited. |
spellingShingle | Epidemiology and Global Health Dowdy, David W Andrews, Jason R Dodd, Peter J Gilman, Robert H A user-friendly, open-source tool to project impact and cost of diagnostic tests for tuberculosis |
title | A user-friendly, open-source tool to project impact and cost of diagnostic tests for tuberculosis |
title_full | A user-friendly, open-source tool to project impact and cost of diagnostic tests for tuberculosis |
title_fullStr | A user-friendly, open-source tool to project impact and cost of diagnostic tests for tuberculosis |
title_full_unstemmed | A user-friendly, open-source tool to project impact and cost of diagnostic tests for tuberculosis |
title_short | A user-friendly, open-source tool to project impact and cost of diagnostic tests for tuberculosis |
title_sort | user-friendly, open-source tool to project impact and cost of diagnostic tests for tuberculosis |
topic | Epidemiology and Global Health |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4082287/ https://www.ncbi.nlm.nih.gov/pubmed/24898755 http://dx.doi.org/10.7554/eLife.02565 |
work_keys_str_mv | AT dowdydavidw auserfriendlyopensourcetooltoprojectimpactandcostofdiagnostictestsfortuberculosis AT andrewsjasonr auserfriendlyopensourcetooltoprojectimpactandcostofdiagnostictestsfortuberculosis AT doddpeterj auserfriendlyopensourcetooltoprojectimpactandcostofdiagnostictestsfortuberculosis AT gilmanroberth auserfriendlyopensourcetooltoprojectimpactandcostofdiagnostictestsfortuberculosis AT dowdydavidw userfriendlyopensourcetooltoprojectimpactandcostofdiagnostictestsfortuberculosis AT andrewsjasonr userfriendlyopensourcetooltoprojectimpactandcostofdiagnostictestsfortuberculosis AT doddpeterj userfriendlyopensourcetooltoprojectimpactandcostofdiagnostictestsfortuberculosis AT gilmanroberth userfriendlyopensourcetooltoprojectimpactandcostofdiagnostictestsfortuberculosis |